Transcutaneous Spinal Cord Stimulation With Robotic Gait Training in Chronic SCI
A Pilot Study on the Cumulative Effects of Transcutaneous Spinal Cord Stimulation (tSCS) With Robotic Gait Training in Trunk Muscle Activity and Walking Index in Chronic Spinal Cord Injury
1 other identifier
interventional
6
1 country
1
Brief Summary
This study is aimed to evaluate whether transcutaneous spinal cord stimulation (tSCS) can augment robotic gait training (RGT) to improve functional mobility in participants with chronic spinal cord injuries. It also evaluate the impact of the tSCS+RGT on health-related quality of life (HRQOL), compared to RGT alone. This is a prospective single-arm crossover study in participants with incomplete chronic traumatic spinal cord injury. 6 subjects with paraplegia and 6 subjects with tetraplegia will be recruited. The intervention includes Phase 1 of training which consists of 16 sessions of robotic gait training (RGT) + conventional physiotherapy in 8-10 weeks, and Phase 2 of training which consists of 16 sessions of RGT training + tSCS + conventional physiotherapy in 8-10 weeks. Outcome measures including mobility function assessment and neuromuscular assessment will be collected at Baseline, Post-Phase 1 and Post-Phase 2. A satisfaction survey on the intervention "RGT training + tSCS + conventional physiotherapy" will be performed at week-18 assessment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 19, 2023
CompletedFirst Posted
Study publicly available on registry
June 27, 2023
CompletedStudy Start
First participant enrolled
November 13, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
February 23, 2026
May 1, 2025
1.8 years
June 19, 2023
February 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (15)
Spinal Cord Injury - Trunk Control Test (SCI-TCT)
It measures 4 simple aspect of trunk movement: 1) rolling to weak side; 2) rolling to strong side; 3) balance in sitting position; 4) sit up from lying down. The final score ranges from 0 (minimum) to 100 (maximum, indicating better performance)
Week 0
Spinal Cord Injury - Trunk Control Test (SCI-TCT)
It measures 4 simple aspect of trunk movement: 1) rolling to weak side; 2) rolling to strong side; 3) balance in sitting position; 4) sit up from lying down. The final score ranges from 0 (minimum) to 100 (maximum, indicating better performance)
Week 8
Spinal Cord Injury - Trunk Control Test (SCI-TCT)
It measures 4 simple aspect of trunk movement: 1) rolling to weak side; 2) rolling to strong side; 3) balance in sitting position; 4) sit up from lying down. The final score ranges from 0 (minimum) to 100 (maximum, indicating better performance)
Week 17
Walking Index in Spinal Cord Injury-II (WISCI-II)
It is an ordinal scale of 20 items assessing the amount of physical assistance needed, as well as device required, for walking following paralysis that results from spinal cord injury. Final score ranges from 0 (minimum) to 20 (maximum, indicating better performance).
Week 0
Walking Index in Spinal Cord Injury-II (WISCI-II)
It is an ordinal scale of 20 items assessing the amount of physical assistance needed, as well as device required, for walking following paralysis that results from spinal cord injury. Final score ranges from 0 (minimum) to 20 (maximum, indicating better performance).
Week 8
Walking Index in Spinal Cord Injury-II (WISCI-II)
It is an ordinal scale of 20 items assessing the amount of physical assistance needed, as well as device required, for walking following paralysis that results from spinal cord injury. Final score ranges from 0 (minimum) to 20 (maximum, indicating better performance).
Week 17
10-Meter Walk Test (10MWT)
It measures walking speed when subject walks at comfortable speed, covered in the distance of 10 meters. Higher result indicates higher walking speed/better performance.
Week 0
10-Meter Walk Test (10MWT)
It measures walking speed when subject walks at comfortable speed, covered in the distance of 10 meters. Higher result indicates higher walking speed/better performance.
Week 8
10-Meter Walk Test (10MWT)
It measures walking speed when subject walks at comfortable speed, covered in the distance of 10 meters. Higher result indicates higher walking speed/better performance.
Week 17
Central motor conduction time (CMCT)
Measured by transcranial magnetic stimulation (TMS). It is calculated by subtracting the peripheral conduction time (PMCT) from motor evoked potential (MEP) latency elicited by TMS to the motor cortex. Higher results indicates longer central motor conduction time and poor performance.
Week 0
Central motor conduction time (CMCT)
Measured by transcranial magnetic stimulation (TMS). It is calculated by subtracting the peripheral conduction time (PMCT) from motor evoked potential (MEP) latency elicited by TMS to the motor cortex. Higher results indicates longer central motor conduction time and poor performance.
Week 8
Central motor conduction time (CMCT)
Measured by transcranial magnetic stimulation (TMS). It is calculated by subtracting the peripheral conduction time (PMCT) from motor evoked potential (MEP) latency elicited by TMS to the motor cortex. Higher results indicates longer central motor conduction time and poor performance.
Week 17
International standards for Neurological Classification of SCI (ISNCSCI)
The test is to define and describe the extent and severity of a patient's spinal cord injury. The patient's grade is based on how much sensation he or she can feel at multiple points on the body, as well as tests of motor function. The results ranged from A (worst- complete lack of motor and sensory function below the level of injury) to E (best, all neurologic function has returned)
Week 0
International standards for Neurological Classification of SCI (ISNCSCI)
The test is to define and describe the extent and severity of a patient's spinal cord injury. The patient's grade is based on how much sensation he or she can feel at multiple points on the body, as well as tests of motor function. The results ranged from A (worst- complete lack of motor and sensory function below the level of injury) to E (best, all neurologic function has returned)
Week 8
International standards for Neurological Classification of SCI (ISNCSCI)
The test is to define and describe the extent and severity of a patient's spinal cord injury. The patient's grade is based on how much sensation he or she can feel at multiple points on the body, as well as tests of motor function. The results ranged from A (worst- complete lack of motor and sensory function below the level of injury) to E (best, all neurologic function has returned)
Week 17
Secondary Outcomes (9)
EQ5D
Week 0
EQ5D
Week 8
EQ5D
Week 17
Modified Tardieu Scale
Week 0
Modified Tardieu Scale
Week 8
- +4 more secondary outcomes
Study Arms (2)
RGT+ conventional physiotherapy
ACTIVE COMPARATOR16 sessions of robotic gait training (RGT) + conventional physiotherapy in 8-10 weeks
RGT+ tSCS + conventional physiotherapy
EXPERIMENTALPhase 2: 16 sessions of RGT training + transcutaneous electrical stimulation (tSCS) + functional training in 8-10 weeks.
Interventions
Subject will undergo 16 sessions of robotic gait training (RGT) + tSCS+ conventional physiotherapy in 8-10 weeks. Subject will walk with EksoGT for gait training during RGT training. Components of conventional physiotherapy will include upper/lower limb ergometry and strength training as prescribed by the attending physiotherapist based on their assessment. During tSCS, cathodes will be placed on the T11 and L1 spinous process. Reference/Ground electrodes placed over the ASIS It will be on biphasic mode with an overlap frequency of 10kHz, Burst Frequency of 30Hz, Pulse width of 1ms. Stimulation intensity ranges from 5-100 mA and will be adjusted according to the patient's response. The tSCS stimulation duration for each session will be 45 minutes in conjunction with the RGT training.
Subject will undergo 16 sessions of robotic gait training (RGT) + conventional physiotherapy in 8-10 weeks. Subject will walk with EksoGT for gait training during RGT training. Components of conventional physiotherapy will include upper/lower limb ergometry and strength training as prescribed by the attending physiotherapist based on their assessment.
Eligibility Criteria
You may qualify if:
- Between 6 months to 5 years from the diagnosis of the traumatic SCI and who are not walking independently;
- Age between 21 to 65 years old;
- Incomplete spinal cord injury: ASIA Impairment Scale (AIS) Grade: B-D;
- Spinal cord injury level: T1- L1, or C2-C8;
- SCI-TCT Score \> 13;
- Capable of providing an informed consent;
- Cleared by Neurosurgeons/ Orthopeadic Surgeons for tSCS;
- Meets prerequisites for Ekso wearable robotic exoskeleton training.
You may not qualify if:
- Participant has uncontrolled cardiopulmonary disease or cardiac symptoms as determined by the investigator;
- Participant has any unstable or significant medical condition that is likely to interfere with study procedures or likely to confound performance and outcomes like uncontrolled neuropathic pain, depression, severe cognitive impairment;
- Unstable or uncontrolled autonomic dysreflexia;
- Requires ventilator support;
- Spasms that limit the ability of the subjects to participate in the study training as determined by the investigator;
- Skin conditions that limit the application of tSCS electrodes;
- Active implanted medical devices that may be affected by tSCS;
- Pregnant, planning to become pregnant or breastfeeding;
- Concurrent participation in another drug or device trial that may interfere with this study;
- Participated in wearable exoskeleton training within the last 3 months prior to enrolment.
- Peripheral nerve injury or significant Lumbar Radiculopathy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National University Hospital, Singaporelead
- Alexandra Hospitalcollaborator
Study Sites (1)
Alexandra Hospital
Singapore, Singapore, 159964, Singapore
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gobinathan Chandran, MBBS
National University Hospital, Singapore
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 19, 2023
First Posted
June 27, 2023
Study Start
November 13, 2024
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
February 23, 2026
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share